SCHEMBL18417841

SCHEMBL18417841

c1ccc(N(c2cccc(-c3ccc(N(c4ccccc4)c4cccc5ccccc45)cc3)c2)c2cccc(-c3ccc(N(c4ccccc4)c4cccc5ccccc45)cc3)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 6/20 0.40
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
ALDH1A1 P00352 2/20 0.35
CYP1A2 P05177 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAPT P10636 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
PRSS1 P07477 1/20 0.34
PRSS2 P07478 1/20 0.34
PRSS3 P35030 1/20 0.34
MCL1 Q07820 1/20 0.33
ACMSD Q8TDX5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22876453 1.00 SIGMAR1 (0.40) SIGMAR1CA12CA1CA2CA9
SCHEMBL21031502 1.00 SIGMAR1 (0.40) SIGMAR1CA12CA1CA2CA9
SCHEMBL18417837 1.00 SIGMAR1 (0.40) SIGMAR1CA12CA1CA2CA9
SCHEMBL17567349 1.00 SIGMAR1 (0.40) SIGMAR1CA12CA1CA2CA9
SCHEMBL17567354 1.00 SIGMAR1 (0.40) SIGMAR1CA12CA1CA2CA9
SCHEMBL23108812 1.00 SIGMAR1 (0.40) SIGMAR1CA12CA1CA2CA9
SCHEMBL19705203 0.98 SIGMAR1 (0.39) SIGMAR1CA12CA1CA2CA9
SCHEMBL18417853 0.98 SIGMAR1 (0.39) SIGMAR1CA12CA1CA2CA9
SCHEMBL19558230 0.98 SIGMAR1 (0.39) SIGMAR1CA12CA1CA2CA9
SCHEMBL24054502 0.98 SIGMAR1 (0.41) SIGMAR1CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170033289-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-02-02 US disclosed
US-20170033289-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170033289-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME L1CAM, TELO2, EPCAM SIGMAR1 1541/4885CA12 3665/4885CA1 2700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.